WE vs PubMed Summaries
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
WE
Read full descriptionHide full description
The WE-ACT app is designed to promote better communication between cancer patients and their employers and between cancer patients and their healthcare teams. This app contains helpful information for cancer patients to use during and after treatment. Victoria Blinder, MD, MSc, is a board certified medical oncologist at Memorial Sloan Kettering Cancer Center with a practice that is dedicated to the treatment of patients with cancer. Her research focuses on understanding and addressing disparities in cancer outcomes. She is the primary investigator of the WE-ACT Study, which tests an early version of this mobile health app designed to help cancer patients keep their jobs during and after treatment. Medical Disclosure: This mobile application (βAppβ) is operated by Memorial Sloan Kettering Cancer Center (βMSKβ) and is intended only for users who consented to take part in the research study named Talking to Employers and Medical Staff About Work (WE-ACT). THIS APP IS NOT TO BE USED AS A SUBSTITUTE FOR MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT OF ANY HEALTH CONDITION OR PROBLEM. ANY QUESTIONS REGARDING YOUR OWN HEALTH SHOULD BE ADDRESSED TO YOUR OWN PHYSICIAN OR OTHER HEALTHCARE PROVIDER. The App may contain links to external websites or mobile applications that are not owned or operated by MSK (the βExternal Contentβ). MSK does not control External Content and we are not responsible for the content or performance of those sites. A link to External Content does not imply any agreement with or endorsement of the External Content or any association with the owner or operators of the External Content. You are responsible for viewing and abiding by the terms and conditions of use and the privacy statements of the External Content.
PubMed Summaries
Read full descriptionHide full description
PaperRounds uses AI to turn PubMed papers into structured summaries for medical students, residents, clinicians and researchers β and every line points to the sentence in the paper it comes from. WHAT'S INSIDE β’ Every paper in five minutes Population, intervention, outcome, findings and harms β each backed by a sentence from the abstract. Deep summaries read the open full text. β’ Ask the literature Ask a question: PubMed is searched, up to 30 abstracts read, every sentence with its source. Or request a report from up to 80. β’ See what the numbers support Evidence Check shows design, sample, follow-up and what to watch for β on your phone, free. Flashcards help you remember each paper. β’ Journal club, ready Slides with speaker notes and a one-page handout from any summary. Line up 2β4 papers side by side. β’ Never miss what changed Every Monday, new trials, meta-analyses and guidelines from your journals. For each paper: which guidelines cited it, and whether it was retracted. β’ Get past the paywall, legally Finds legal free copies of a paper β PMC, Europe PMC, repositories β and can summarize the open full text. β’ In your language Every summary, answer and report written in your language β drug names, numbers and PMIDs kept exact. 30 languages. β’ Connect Zotero Papers you summarize go to your Zotero library with the summary attached. Connect in Settings. β’ On iPhone, iPad and iPhone Duo Connect with Apple and your library and topics stay in step across your iPhone and iPad. On iPhone Duo, the unfolded screen gets the wide iPad layout. PAPERROUNDS PRO β’ 50 summaries a day, 10 from the full text Deep summaries read the open full text; every field cites the paper. β’ Ask the literature Ask a question: 30 PubMed abstracts read, every sentence cited. 30 a day. β’ Deep literature report From 80 abstracts: a study table, disagreements and gaps, as a PDF. 3 a day. β’ Side by side, and journal club Compare 2β4 papers in a table. Slides, speaker notes and a one-page handout. β’ After publication The full lists of guidelines, meta-analyses and RCTs that cited a paper. β’ In your language Summaries, answers and reports in 30 languages β drug names, numbers and PMIDs kept exact. Without Pro: Evidence Check, the weekly digest, finding legal free full texts, and one summary to try. RESEARCH AND EDUCATION ONLY PaperRounds helps summarize published medical literature for learning and research. It is not a medical device and does not provide diagnosis or treatment recommendations. Always verify summaries against the original article and your clinical judgment. βββββββ Support: https://www.notion.so/Support-PaperRounds-3660cc7ee73680b5b00cf8327cc176bb?source=copy_link Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Privacy Policy: https://www.notion.so/Privacy-Policy-PaperRounds-3660cc7ee736801a87dcc66cdf6e1c19?source=copy_link
Screenshots
Verdict
The clearest difference is in-app purchases: WE at none against PubMed Summaries's 3. WE also leads on iOS requirement (15.6 vs 18.0). On price, update cadence, ads and device support there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. PubMed Summaries sells 3 in-app purchases, starting at $4.99 per 7 days. WE asks for nothing beyond the download.
WE ships an update every 6 months, PubMed Summaries every 5 months. The most recent releases landed on October 13, 2026 and October 20, 2026 respectively.
| Parameter | WE | PubMed Summaries |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 6 months | Every 5 months β better |
| Ads | No | No |
| In-app purchases | No β better | Yes |
| Devices | iPhone, iPad, iPod β better | iPhone, iPad |
| Requires iOS | 15.6 β better | 18.0 |
| Further details β not scored | ||
| Size | 59 MB | 121 MB |
| Age rating | 17+ | 4+ |
| Developer | Memorial Sloan Kettering Cancer Center | MUHAMMET USLU |
In-app purchases
WE
No in-app purchases
PubMed Summaries
- Weekly Pro3 Days trial$4.997 Days
- Yearly Pro$99.991 Year
- Disposable Production$0.99







